These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12384329)

  • 1. Clinically useful assessments: substance use and comorbid psychiatric disorders.
    Carey KB
    Behav Res Ther; 2002 Nov; 40(11):1345-61. PubMed ID: 12384329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The triply diagnosed: patients with major mental illness, cognitive impairment, and substance abuse.
    Strain EC; Buccino DL; Brooner RK; Schmidt CW; Bigelow GE
    J Nerv Ment Dis; 1993 Sep; 181(9):585-7. PubMed ID: 8245929
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients.
    Strain EC
    Clin J Pain; 2002; 18(4 Suppl):S14-27. PubMed ID: 12479251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe mental illness and addictions: assessment considerations.
    Carey KB; Correia CJ
    Addict Behav; 1998; 23(6):735-48. PubMed ID: 9801713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders.
    DiClemente CC; Nidecker M; Bellack AS
    J Subst Abuse Treat; 2008 Jan; 34(1):25-35. PubMed ID: 17574798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients.
    Swanson AJ; Pantalon MV; Cohen KR
    J Nerv Ment Dis; 1999 Oct; 187(10):630-5. PubMed ID: 10535657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia.
    Kingston REF; Marel C; Mills KL
    Drug Alcohol Rev; 2017 Jul; 36(4):527-539. PubMed ID: 27786426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief motivational feedback may enhance treatment entry in veterans with comorbid substance use and psychiatric disorders.
    Lozano BE; LaRowe SD; Smith JP; Tuerk P; Roitzsch J
    Am J Addict; 2013; 22(2):132-5. PubMed ID: 23414498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized assessment of substance-related, other psychiatric, and comorbid disorders among probationers.
    Lurigio AJ; Cho YI; Swartz JA; Johnson TP; Graf I; Pickup L
    Int J Offender Ther Comp Criminol; 2003 Dec; 47(6):630-52. PubMed ID: 14661384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurring severe mental illness and substance use disorders: a review of recent research.
    RachBeisel J; Scott J; Dixon L
    Psychiatr Serv; 1999 Nov; 50(11):1427-34. PubMed ID: 10543851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment programmes for people with both severe mental illness and substance misuse.
    Ley A; Jeffery DP; McLaren S; Siegfried N
    Cochrane Database Syst Rev; 2000; (2):CD001088. PubMed ID: 10796588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivational Interviewing to Reduce Substance Use in Adolescents with Psychiatric Comorbidity.
    Brown RA; Abrantes AM; Minami H; Prince MA; Bloom EL; Apodaca TR; Strong DR; Picotte DM; Monti PM; MacPherson L; Matsko SV; Hunt JI
    J Subst Abuse Treat; 2015 Dec; 59():20-9. PubMed ID: 26362000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse and family relationships of persons with severe mental illness.
    Dixon L; McNary S; Lehman A
    Am J Psychiatry; 1995 Mar; 152(3):456-8. PubMed ID: 7864278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.